Germany vs Latvia: Share of S. aureus infections resistant to methicillin
Germany
4.4%
in 2022
Latvia
3.8%
in 2022
Germany rank
38th
Latvia rank
41st
Share of S. aureus infections resistant to methicillin over time
- Germany
- Latvia
How they compare
Germany currently reports 4.4% against 3.8% in Latvia, a difference of 0.6%.
That makes Germany's figure about 1.2 times Latvia's.
The two have swapped places 2 times across 7 shared years of data; in 2016 it was Germany ahead.
Germany ranks 38th and Latvia ranks 41st of 45 countries.
Across the 2 decades both report, Germany averaged higher in 1 and Latvia in 1.
Head to head by decade
| Decade | Germany | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.4% | 5.4% | 3.0% | Germany |
| 2020s | 5.0% | 7.3% | 2.4% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Germany or Latvia?
- Germany, at 4.4% against 3.8% in Latvia as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Germany and Latvia?
- 0.6%, with Germany ahead.
- How many years of comparable data are there for Germany and Latvia?
- 7 years are reported by both, from 2016 to 2022.
- How do Germany and Latvia rank globally for share of s. aureus infections resistant to methicillin?
- Germany ranks 38th and Latvia ranks 41st of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).